U.S., Sept. 24 -- An application to own the trademark for 'SYNTAX' has been filed on Jul. 20, 2022.
Owner(s):
DNA SCRIPT; 67 avenue de Fontainebleau, LE KREMLIN-BICÊTRE F-94270, FRANCE
Goods and/or Services:
For: Chemical reagents and enzymes for medical use, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling, modifying genetic fragments, genotyping, gene modification, and analysis of biological systems, samples and cells, in clinical, medical and biological facilities and laboratories using or storing nucleic acid molecules; stem cells for medical use; stem cells for veterinary use; all the aforesaid goods other than those directly for use in the cardiovascular field
Class(es): 005, 006, 018, 044, 046,...